Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108938212> ?p ?o ?g. }
- W3108938212 endingPage "100" @default.
- W3108938212 startingPage "87" @default.
- W3108938212 abstract "Pancreatic ductal adenocarcinoma (PDAC), a metabolic disorder, remains one of the leading cancer mortality sources worldwide. An initial response to treatments, such as gemcitabine (GEM), is often followed by emergent resistance reflecting an urgent need for alternate therapies. The PDAC resistance to GEM could be due to ERK1/2 activity. However, successful ERKi therapy is hindered due to low ligand efficiency, poor drug delivery, and toxicity. In this study, to overcome these limitations, we have designed pH-responsive nanoparticles (pHNPs) with a size range of 100–150 nm for the simultaneous delivery of ERKi (SCH 772984) and GEM with tolerable doses. These pHNPs are polyethylene glycol (PEG)-containing amphiphilic polycarbonate block copolymers with tertiary amine side chains. They are systemically stable and capable of improving in vitro and in vivo drug delivery at the cellular environment’s acidic pH. The functional analysis indicates that the nanomolar doses of ERKi or GEM significantly decreased the 50% growth inhibition (IC50) of PDAC cells when encapsulated in pHNPs compared to free drugs. The combination of ERKi with GEM displayed a synergistic inhibitory effect. Unexpectedly, we uncover that the minimum effective dose of ERKi significantly promotes GEM activities on PDAC cells. Furthermore, we found that pHNP-encapsulated combination therapy of ERKi with GEM was superior to unencapsulated combination drug therapy. Our findings, thus, reveal a simple, yet efficient, drug delivery approach to overcome the limitations of ERKi for clinical applications and present a new model of sensitization of GEM by ERKi with no or minimal toxicity." @default.
- W3108938212 created "2020-12-07" @default.
- W3108938212 creator A5002666742 @default.
- W3108938212 creator A5006522980 @default.
- W3108938212 creator A5014281779 @default.
- W3108938212 creator A5017739829 @default.
- W3108938212 creator A5030669085 @default.
- W3108938212 creator A5031790946 @default.
- W3108938212 creator A5033249268 @default.
- W3108938212 creator A5038008974 @default.
- W3108938212 creator A5044523133 @default.
- W3108938212 creator A5045069219 @default.
- W3108938212 creator A5047729425 @default.
- W3108938212 creator A5058111868 @default.
- W3108938212 creator A5059668423 @default.
- W3108938212 creator A5075039061 @default.
- W3108938212 creator A5085674979 @default.
- W3108938212 date "2020-11-24" @default.
- W3108938212 modified "2023-10-16" @default.
- W3108938212 title "pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer" @default.
- W3108938212 cites W1898150109 @default.
- W3108938212 cites W1920802447 @default.
- W3108938212 cites W1940824108 @default.
- W3108938212 cites W1964847767 @default.
- W3108938212 cites W1966438319 @default.
- W3108938212 cites W1973758133 @default.
- W3108938212 cites W1978959100 @default.
- W3108938212 cites W1981084922 @default.
- W3108938212 cites W1983452367 @default.
- W3108938212 cites W1987406340 @default.
- W3108938212 cites W1997787046 @default.
- W3108938212 cites W2004955040 @default.
- W3108938212 cites W2017974831 @default.
- W3108938212 cites W2018896819 @default.
- W3108938212 cites W2020201038 @default.
- W3108938212 cites W2027432937 @default.
- W3108938212 cites W2029038878 @default.
- W3108938212 cites W2037270637 @default.
- W3108938212 cites W2040071171 @default.
- W3108938212 cites W2045246542 @default.
- W3108938212 cites W2047101821 @default.
- W3108938212 cites W2051432136 @default.
- W3108938212 cites W2051708290 @default.
- W3108938212 cites W2053809294 @default.
- W3108938212 cites W2061139525 @default.
- W3108938212 cites W2075370047 @default.
- W3108938212 cites W2080534618 @default.
- W3108938212 cites W2081990599 @default.
- W3108938212 cites W2082511916 @default.
- W3108938212 cites W2088857894 @default.
- W3108938212 cites W2098799992 @default.
- W3108938212 cites W2100436479 @default.
- W3108938212 cites W2101902313 @default.
- W3108938212 cites W2112474929 @default.
- W3108938212 cites W2115658546 @default.
- W3108938212 cites W2116386978 @default.
- W3108938212 cites W2126649494 @default.
- W3108938212 cites W2126669622 @default.
- W3108938212 cites W2128860199 @default.
- W3108938212 cites W2129370444 @default.
- W3108938212 cites W2147924229 @default.
- W3108938212 cites W2151253787 @default.
- W3108938212 cites W2156182235 @default.
- W3108938212 cites W2156266195 @default.
- W3108938212 cites W2159476762 @default.
- W3108938212 cites W2164286021 @default.
- W3108938212 cites W2167795547 @default.
- W3108938212 cites W2167891407 @default.
- W3108938212 cites W2170471719 @default.
- W3108938212 cites W2175275937 @default.
- W3108938212 cites W2192729804 @default.
- W3108938212 cites W2211890826 @default.
- W3108938212 cites W2223535266 @default.
- W3108938212 cites W2225173575 @default.
- W3108938212 cites W2290466312 @default.
- W3108938212 cites W2299106188 @default.
- W3108938212 cites W2317040119 @default.
- W3108938212 cites W2317360364 @default.
- W3108938212 cites W2325105010 @default.
- W3108938212 cites W2409321676 @default.
- W3108938212 cites W2424134693 @default.
- W3108938212 cites W2561583042 @default.
- W3108938212 cites W2576156325 @default.
- W3108938212 cites W2587823650 @default.
- W3108938212 cites W2588221525 @default.
- W3108938212 cites W2622499649 @default.
- W3108938212 cites W2743342011 @default.
- W3108938212 cites W2745610816 @default.
- W3108938212 cites W2776551032 @default.
- W3108938212 cites W2781525129 @default.
- W3108938212 cites W2783551232 @default.
- W3108938212 cites W2785632196 @default.
- W3108938212 cites W2789608969 @default.
- W3108938212 cites W2898386214 @default.
- W3108938212 cites W2910268222 @default.
- W3108938212 cites W2911188335 @default.
- W3108938212 cites W2917335837 @default.
- W3108938212 cites W2920097475 @default.